Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jansen, A. P.
Right arrow Articles by Colburn, N. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jansen, A. P.
Right arrow Articles by Colburn, N. H.
[Cancer Research 65, 6034-6041, July 15, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis

Aaron P. Jansen, Corinne E. Camalier and Nancy H. Colburn

Gene Regulation Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland

Requests for reprints: Aaron P. Jansen, National Cancer Institute-Frederick, Building 567, Room 187, Frederick, MD 21702. Phone: 301-846-6850; Fax: 301-846-6907; E-mail: ajansen{at}ncifcrf.gov.

Programmed cell death 4 (Pdcd4) is a novel repressor of in vitro transformation. Pdcd4 directly inhibits the helicase activity of eukaryotic translation initiation factor 4A, a component of the translation initiation complex. To ascertain whether Pdcd4 suppresses tumor development in vivo, we have generated transgenic mice that overexpress Pdcd4 in the epidermis (K14-Pdcd4). K14-regulated Pdcd4 expression caused a neonatal short-hair phenotype due to early catagen entry compared with matched wild-type siblings. In response to the 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA) mouse skin carcinogenesis protocol, K14-Pdcd4 mice showed significant reductions in papilloma formation, carcinoma incidence, and papilloma-to-carcinoma conversion frequency compared with wild-type mice. The translational efficiency of an mRNA engineered to form a structured 5' untranslated region (UTR) was attenuated in primary keratinocytes when Pdcd4 was overexpressed. Pdcd4 inhibited by 46% TPA-induced activator protein-1 (AP-1)–dependent transcription, an event required for tumorigenesis. CDK4 and ornithine decarboxylase (ODC) are candidates for Pdcd4-regulated translation as their mRNAs contain 5'structured UTRs. In K14-Pdcd4 primary keratinocytes expressing activated Ha-Ras to mimic DMBA-initiated epidermis, ODC and CDK4 protein levels were decreased by 40% and 46%, respectively. Expression of a protein encoded by 5' unstructured mRNA showed no change. These results extend to an in vivo model the observations that Pdcd4 inhibits both translation initiation and AP-1 activation while decreasing benign tumor development and malignant progression. The K14-Pdcd4 mice seem to validate translation initiation as a novel target for cancer prevention.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Carayol, E. Katsoulidis, A. Sassano, J. K. Altman, B. J. Druker, and L. C. Platanias
Suppression of Programmed Cell Death 4 (PDCD4) Protein Expression by BCR-ABL-regulated Engagement of the mTOR/p70 S6 Kinase Pathway
J. Biol. Chem., March 28, 2008; 283(13): 8601 - 8610.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Schmid, A. P. Jansen, A. R. Baker, G. Hegamyer, J. P. Hagan, and N. H. Colburn
Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion
Cancer Res., March 1, 2008; 68(5): 1254 - 1260.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. B. Frankel, N. R. Christoffersen, A. Jacobsen, M. Lindow, A. Krogh, and A. H. Lund
Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells
J. Biol. Chem., January 11, 2008; 283(2): 1026 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
N. LaRonde-LeBlanc, A. N. Santhanam, A. R. Baker, A. Wlodawer, and N. H. Colburn
Structural Basis for Inhibition of Translation by the Tumor Suppressor Pdcd4
Mol. Cell. Biol., January 1, 2007; 27(1): 147 - 156.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. Ozpolat, U. Akar, M. Steiner, I. Zorrilla-Calancha, M. Tirado-Gomez, N. Colburn, M. Danilenko, S. Kornblau, and G. Lopez Berestein
Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid-Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia Cells
Mol. Cancer Res., January 1, 2007; 5(1): 95 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hilliard, B. Hilliard, S.-J. Zheng, H. Sun, T. Miwa, W. Song, R. Goke, and Y. H. Chen
Translational Regulation of Autoimmune Inflammation and Lymphoma Genesis by Programmed Cell Death 4
J. Immunol., December 1, 2006; 177(11): 8095 - 8102.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
N. V. Dorrello, A. Peschiaroli, D. Guardavaccaro, N. H. Colburn, N. E. Sherman, and M. Pagano
S6K1- and {beta}TRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth.
Science, October 20, 2006; 314(5798): 467 - 471.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Jin, T. H. Kim, S.-K. Hwang, S.-H. Chang, H. W. Kim, H. K. Anderson, H.-W. Lee, K.-H. Lee, N. H. Colburn, H.-S. Yang, et al.
Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice.
Mol. Cancer Ther., April 1, 2006; 5(4): 1041 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H.-S. Yang, C. P. Matthews, T. Clair, Q. Wang, A. R. Baker, C.-C. H. Li, T.-H. Tan, and N. H. Colburn
Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion
Mol. Cell. Biol., February 15, 2006; 26(4): 1297 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Palamarchuk, A. Efanov, V. Maximov, R. I. Aqeilan, C. M. Croce, and Y. Pekarsky
Akt Phosphorylates and Regulates Pdcd4 Tumor Suppressor Protein
Cancer Res., December 15, 2005; 65(24): 11282 - 11286.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.